Syndax Pharmaceuticals Inc (SNDX) income statement
SNDXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$8.72−0.41 (-4.49%)
Close on Nov 20, 2026Market cap $778.67MP/E –Yield –
Syndax Pharmaceuticals Inc financial ratios
See a number that looks wrong?